Climate Change Data

Futura Medical plc

Climate Impact & Sustainability Data (2022)

Reporting Period: 2022

Environmental Metrics

ESG Focus Areas

  • Gender Equality
  • Industry, Innovation and Infrastructure
  • Decent Work and Economic Growth
  • Good Health and Well-being

Social Achievements

  • Supported employment policies and practices that make provision for equal opportunities and non-discrimination in our workforce.
  • Place the health and safety of our staff and consultants at the heart of our business and have adopted a policy to allow our staff to optionally work approximately 50% of the time from home giving them the flexibility to balance their work and family commitments.

Climate Goals & Targets

Short-term Goals:
  • Approval of MED3000 by the US FDA as an OTC medical device in Q2 2023.
  • First launches of MED3000 under the brand name Eroxon® in Europe with further launches planned in 2023, with first revenues reported.
  • Sign further agreements for key markets and countries worldwide – with the USA being the main focus – to build a strong global network of licensing and distribution partners and a strong brand identity for MED3000.

Environmental Challenges

  • R&D risk: Regulatory approvals may not be obtained or maintained, and timelines may be inaccurate.
  • Commercial risk: Establishing and maintaining relationships with licensing partners is uncertain, and even with approvals, products may not be launched, promoted, or accepted.
  • Financial risk: The Group is expected to remain loss-making in the short term, and sufficient funds may not be available to execute business plans.
  • Disruption to supply products: Reliance on third-party manufacturers poses a risk of financial and reputational loss.
  • Intellectual property risk: Obtaining and maintaining sufficiently broad patents is crucial for commercial success.
  • Key people risk: The expertise and experience of key personnel are vital for business results.
  • Economic and political conditions: Downturns in economic conditions and geopolitical events can impact raw material prices, energy costs, and capital availability.
Mitigation Strategies
  • Developing products using safe compounds, seeking regulatory advice, and working with experienced commercial partners.
  • Carefully selecting experienced commercial partners, maintaining relationships, and developing new products.
  • Securing licensing and distribution agreements, monitoring sales against forecasts, and communicating with shareholders and investors.
  • Clearly defined agreements with suppliers, close oversight of their processes, stockpiling of raw materials, and exploring alternative supply sources.
  • Developing products with potential patent protection, maintaining confidentiality agreements, and monitoring technological developments.
  • Offering a merit-based work environment, competitive rewards, and long-term incentives.
  • Monitoring the impact of economic and political events and taking appropriate actions.

Supply Chain Management

Climate-Related Risks & Opportunities

Reporting Standards

Frameworks Used: UN Sustainable Development Goals (SDGs)

UN Sustainable Development Goals

  • Goal 5: Gender equality
  • Goal 9: Industry, innovation and infrastructure
  • Goal 8: Decent work and economic growth
  • Goal 3: Good health and well-being

The company's activities contribute to these goals through its commitment to gender equality, investment in R&D, focus on decent work practices, and development of medical products that improve health and well-being.